0
0
Industry
Geography
Report Type
Price
Publication date
Published Date
  • Company Profile

    $295 | January 2024
    Company Profile

    ThermoGenesis Holdings Inc – Company Profile

    ThermoGenesis Holdings Inc (ThermoGenesis), formerly Cesca Therapeutics Inc, researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its offers AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics,...

    Add to Basket
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.